Virpax Pharmaceuticals, Inc. (VRPX) Stock Price & Analysis
Virpax Pharmaceuticals, Inc. (VRPX) closed at USD 0 on Friday, October 23, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0; the Oct 23, 2026 session ranged USD 0.02–0.02 on volume of 51 shares. Market capitalization is —, with a 52-week range of USD 0–0.1 (PNK). Source: Nexqual, retrieved October 24, 2026 at 12:39 UTC.
Also available as compact Markdown for AI agents: nexqual.com/VRPX.md
Key facts (VRPX)
- Total return with dividends: 1Y -96.2% vs S&P 500 +13.4%; 5Y -100.0% vs S&P 500 +76.9%.
Total return (dividends reinvested) (VRPX)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -96.2% | -100.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -96.2% | -94.0% |
| Volatility (annualized) | 1320.7% | 542.4% |
| Max drawdown | -99.9% (Dec 2025→Mar 2026) | -100.0% (Nov 2021→May 2026) |
VRPX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Mar 2025) | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends Dec 2025) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 12:39 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.1 |
| Volume | 51 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (VRPX)
Nexqual's technical model rates VRPX "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 12:39 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.72 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Earnings (VRPX)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-12-31 | USD 12.5 vs est -6.75 ▲ beat |
| 2024-09-30 | USD -10.75 vs est -13.5 ▲ beat |
| 2024-06-30 | USD -43.75 vs est -38.25 ▼ miss |
Source: Nexqual, October 24, 2026 at 12:39 UTC.
Financials & Fundamentals (VRPX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -2364.82% |
| Current Ratio | 0.63 |
| Total Cash | $1.51M |
| Total Debt | $0 |
Source: Nexqual, October 24, 2026 at 12:39 UTC.
Ownership (VRPX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 1.24M |
| Float | 1.06M |
| Short % of Float | +25.74% |
Source: Nexqual, October 24, 2026 at 12:39 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MDIA | Mediaco Holding Inc. | USD 1.1 | ▼ 1.79% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.47 | ▼ 8.02% |
| NRXP | NRX Pharmaceuticals, Inc. | USD 2.49 | ▲ 3.75% |
| INDP | Indaptus Therapeutics, Inc. | USD 3.16 | ▲ 5.69% |
| PTPI | Petros Pharmaceuticals, Inc. | USD 0 | ▼ 0% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 12:39 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt